Category: Cataract

The iStent Receives FDA Approval

The iStent Trabecular Micro-Bypass (Glaukos
Corporation) has received approval from the FDA, a
decision that has the potential to change the way glaucoma
is treated in the United States. The iStent, which
is the first ab interno glaucoma implant to be …

AMO’s Mazzo to Retire at Year’s End

James V. Mazzo, senior vice president of Abbott
Medical Optics Inc. (AMO), announced his plans to
retire from AMO at the end of the year. The news was
shared internally at AMO headquarters on May 17. The
company announced that Mr. Mazzo will be replace…